Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Albert Martin who wrote (7562)	4/29/1999 4:50:00 PM
From: Stuart Carmichael	Read Replies (1) \| Respond to of 9523

Pfizer was at $115.00 before they announced the split. The Dow has put on 2000 points since. All in all, it looks like $100.00 is just around the corner.

To: Albert Martin who wrote (7562)	4/29/1999 6:37:00 PM
From: American Spirit	Respond to of 9523

PFE has come down a long way already. I heard an analyst on CNBC the other day say that the drug stocks should be near a bottom. That was two-three days ago. Sure it's a gamble but there's less and less to lose. If it held today that's a good sign because negativity was in the air. Friday is always a tricky day. Further dips tomorrow should be looked at by an optimistic investor as another buying opportunity. I feel good with my shares at average 117. Rotation in the marketplace has been consistent recently. Drug stocks and quality techs may join cyclicals now that their PE's have been bashed down to earth. Maybe you're right though. You never know what the bottom is until you get there. Still, longer term this is a good price to buy. And PFE IS a longterm kind of investment.